We are live on
!
Find out more
PHP
Parkman Healthcare Partners Portfolio holdings
AUM
$970M
1-Year Est. Return
79.46%
This Fund
S&P 500
This Quarter
Est. Return
+20.86%
1 Year Est. Return
+79.46%
3 Year Est. Return
+312.89%
5 Year Est. Return
+648.59%
10 Year Est. Return
–
AUM
$710M
AUM Growth
+$164M
(+30%)
Cap. Flow
+$64.1M
Cap. Flow
% of AUM
9.04%
Top 10 Holdings %
Top 10 Hldgs %
36.24%
Holding
113
New
11
Increased
54
Reduced
24
Closed
24
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$15.7M |
| 2 |
Inspire Medical Systems
INSP
|
+$12.4M |
| 3 |
Amgen
AMGN
|
+$11.3M |
| 4 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$10.7M |
| 5 |
Qiagen
QGEN
|
+$10M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HCA Healthcare
HCA
|
+$13.8M |
| 2 |
IMGN
Immunogen Inc
IMGN
|
+$11.4M |
| 3 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
+$8.68M |
| 4 |
Charles River Laboratories
CRL
|
+$8.65M |
| 5 |
Zimmer Biomet
ZBH
|
+$7.97M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 98.72% |
| 2 | Industrials | 0.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Natera
NTRA
$45.5B
| – | – |
-50,751
| Closed | -$2.25M |
|
102
Pacific Biosciences
PACB
$345M
| – | – |
-210,580
| Closed | -$1.76M |
|
|
SLNO
103
DELISTED
Soleno Therapeutics
SLNO
| – | – |
-100,000
| Closed | -$2.95M |
|
|
TERN
104
DELISTED
Terns Pharmaceuticals
TERN
| – | – |
-41,728
| Closed | -$210K |
|
105
Voyager Therapeutics
VYGR
$197M
| – | – |
-60,322
| Closed | -$467K |
|
|
106
Zimmer Biomet
ZBH
$18.7B
| – | – |
-71,000
| Closed | -$7.97M |
|
|
CUTR
107
DELISTED
Cutera, Inc.
CUTR
| – | – |
-100,000
| Closed | -$602K |
|
|
CDMO
108
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| – | – |
-185,613
| Closed | -$1.75M |
|
|
CTLT
109
DELISTED
CATALENT, INC.
CTLT
| – | – |
-80,646
| Closed | -$3.67M |
|
|
MORF
110
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| – | – |
-75,000
| Closed | -$1.72M |
|
|
AFIB
111
DELISTED
Acutus Medical Inc
AFIB
| – | – |
-794,145
| Closed | -$553K |
|
|
KRTX
112
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| – | – |
-51,311
| Closed | -$8.68M |
|
|
IMGN
113
DELISTED
Immunogen Inc
IMGN
| – | – |
-717,920
| Closed | -$11.4M |
|
Similar funds
LOIM
MGCM
JWM
WAM
GHC
SAM
TCCM
UIC
Parkman Healthcare Partners's Q4 2023 Portfolio in Review
As of Q4 2023, Parkman Healthcare Partners held 113 positions worth $710M, up 30% from $546M the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Parkman Healthcare Partners deployed $64.1M of net new capital in Q4 2023, opening 11 new positions and adding to 54 existing holdings. Its largest new stake was Abbott: 156,727 shares worth $17.3M.
By sector, the portfolio is most concentrated in Healthcare at 99% of assets, down from 100% a quarter earlier, followed by Industrials.
On the sell side, the largest reduction was Becton Dickinson, an estimated $7.52M trimmed.
- Parkman Healthcare Partners's largest Q4 2023 buy was Abbott: 156,727 shares worth $17.3M.
- Parkman Healthcare Partners added most to Inspire Medical Systems in Q4 2023, an estimated $12.4M increase.
- Parkman Healthcare Partners's biggest Q4 2023 reduction was Becton Dickinson, cutting an estimated $7.52M.
- Parkman Healthcare Partners fully exited HCA Healthcare in Q4 2023, selling an estimated $13.8M.
- Parkman Healthcare Partners's ten largest holdings make up 36% of its $710M portfolio in Q4 2023.
- Parkman Healthcare Partners opened 11 new positions and closed 24 in Q4 2023.
- Parkman Healthcare Partners's portfolio value rose 30% quarter-over-quarter to $710M.
Based on Parkman Healthcare Partners's 13F filing for Q4 2023, filed 14 Feb 2024.